SlideShare une entreprise Scribd logo
1  sur  45
Journal Club Dr Sidharth Kumar Sethi MD, Fellowship [IPNA, ISN, ISPN] https://www.pediatric-nephrology.com
Background ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Infections and Relapses ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Short term daily steroids during infections ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Research Question ,[object Object]
Aim of the study ,[object Object],[object Object],[object Object],[object Object],[object Object]
Study Design ,[object Object],[object Object],[object Object],[object Object]
Inclusion criteria ,[object Object],[object Object],[object Object],[object Object]
Exclusion Criteria ,[object Object],[object Object],[object Object],[object Object]
Standard Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Randomisation ,[object Object],[object Object],[object Object],[object Object]
Intervention ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Follow up ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Relapse definition and management ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Follow up ,[object Object],[object Object],[object Object],[object Object]
Serious Infections ,[object Object],[object Object],[object Object],[object Object]
Outcomes ,[object Object],[object Object],[object Object],[object Object],[object Object]
Premature termination  ,[object Object],[object Object],[object Object],[object Object]
Sample Size ,[object Object],[object Object],[object Object],[object Object]
Statistical Analysis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Incidence Density Rates ,[object Object],[object Object]
Example of Relapse Rates ,[object Object],[object Object],[object Object]
Statistical Analysis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Rate Ratio ,[object Object],[object Object],[object Object]
Number needed to Treat ,[object Object],[object Object],[object Object]
NNT Example Prophylaxis RF No RF Total Risk Yes 15 285 300 0.05 No 49 251 300 0.16 ARR 0.11 NNT 9
68 patients alternate-day prednisolone alone (strata 1) 32 received alternate-day prednisolone and levamisole (strata 2)
 
Relapse rates @ 12 months ,[object Object],[object Object]
 
Infections ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Infection Relapse Correlation
Adjusted Analysis & Number Needed to Treat ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Treatment failures and Add on therapy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Sub-group Analysis
Discussion: Salient points of results ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Previous studies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Previous studies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Infections ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
More infections in intervention group! ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Critical Appraisal  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Limitations ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Limitations ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Conclusions ,[object Object],[object Object]
[object Object]

Contenu connexe

Tendances

Fluid in pancreatitis final
Fluid in pancreatitis finalFluid in pancreatitis final
Fluid in pancreatitis finalYouttam Laudari
 
Journal club Neonatology
Journal club NeonatologyJournal club Neonatology
Journal club NeonatologyDr Inayat Ullah
 
Abd Pain ER Case Presentation
Abd Pain ER Case PresentationAbd Pain ER Case Presentation
Abd Pain ER Case Presentationjcm MD
 
Growth charts in Neonates- Preterm and term
Growth charts in Neonates- Preterm and termGrowth charts in Neonates- Preterm and term
Growth charts in Neonates- Preterm and termSujit Shrestha
 
Non diabetic renal disease with or without diabetic nephropathy dr.amgad el-...
Non diabetic renal disease with or without diabetic nephropathy  dr.amgad el-...Non diabetic renal disease with or without diabetic nephropathy  dr.amgad el-...
Non diabetic renal disease with or without diabetic nephropathy dr.amgad el-...FarragBahbah
 
OSCE Pediatrics Observed Stations Dr.D.Y.Patil Medical College CME
OSCE Pediatrics Observed Stations Dr.D.Y.Patil Medical College CMEOSCE Pediatrics Observed Stations Dr.D.Y.Patil Medical College CME
OSCE Pediatrics Observed Stations Dr.D.Y.Patil Medical College CMEDr Padmesh Vadakepat
 
Lupus Nephritis Guideline Review 2022
Lupus Nephritis Guideline Review 2022Lupus Nephritis Guideline Review 2022
Lupus Nephritis Guideline Review 2022Sidney Erwin Manahan
 
Liver stiffness measurement (fibroscan®)
Liver stiffness measurement (fibroscan®)Liver stiffness measurement (fibroscan®)
Liver stiffness measurement (fibroscan®)Samir Haffar
 
Journal club- Enteral Paracetamol or IV Indomethacin for closure of PDA
Journal club- Enteral Paracetamol or IV Indomethacin for closure of PDAJournal club- Enteral Paracetamol or IV Indomethacin for closure of PDA
Journal club- Enteral Paracetamol or IV Indomethacin for closure of PDAZaheen Zehra
 
Chronic liver disease in children 2021
Chronic liver disease in children 2021Chronic liver disease in children 2021
Chronic liver disease in children 2021Imran Iqbal
 
Acute-on-chronic liver failure (ACLF).pptx
Acute-on-chronic liver failure (ACLF).pptxAcute-on-chronic liver failure (ACLF).pptx
Acute-on-chronic liver failure (ACLF).pptxssusere071fa
 
Sepsis power point presentation
Sepsis power point presentationSepsis power point presentation
Sepsis power point presentationdlecolst
 
Surviving Sepsis Guidelines Updated
Surviving Sepsis Guidelines UpdatedSurviving Sepsis Guidelines Updated
Surviving Sepsis Guidelines UpdatedSun Yai-Cheng
 

Tendances (20)

Fluid in pancreatitis final
Fluid in pancreatitis finalFluid in pancreatitis final
Fluid in pancreatitis final
 
Journal club Neonatology
Journal club NeonatologyJournal club Neonatology
Journal club Neonatology
 
CAPE COD trial.pptx
CAPE COD trial.pptxCAPE COD trial.pptx
CAPE COD trial.pptx
 
Abd Pain ER Case Presentation
Abd Pain ER Case PresentationAbd Pain ER Case Presentation
Abd Pain ER Case Presentation
 
Growth charts in Neonates- Preterm and term
Growth charts in Neonates- Preterm and termGrowth charts in Neonates- Preterm and term
Growth charts in Neonates- Preterm and term
 
pediatric AML
pediatric AMLpediatric AML
pediatric AML
 
Non diabetic renal disease with or without diabetic nephropathy dr.amgad el-...
Non diabetic renal disease with or without diabetic nephropathy  dr.amgad el-...Non diabetic renal disease with or without diabetic nephropathy  dr.amgad el-...
Non diabetic renal disease with or without diabetic nephropathy dr.amgad el-...
 
RIPE 2012 Pediatrics OSCE
RIPE 2012 Pediatrics OSCERIPE 2012 Pediatrics OSCE
RIPE 2012 Pediatrics OSCE
 
OSCE Pediatrics Observed Stations Dr.D.Y.Patil Medical College CME
OSCE Pediatrics Observed Stations Dr.D.Y.Patil Medical College CMEOSCE Pediatrics Observed Stations Dr.D.Y.Patil Medical College CME
OSCE Pediatrics Observed Stations Dr.D.Y.Patil Medical College CME
 
Hemophilia presentation
Hemophilia presentationHemophilia presentation
Hemophilia presentation
 
Lupus Nephritis Guideline Review 2022
Lupus Nephritis Guideline Review 2022Lupus Nephritis Guideline Review 2022
Lupus Nephritis Guideline Review 2022
 
Liver stiffness measurement (fibroscan®)
Liver stiffness measurement (fibroscan®)Liver stiffness measurement (fibroscan®)
Liver stiffness measurement (fibroscan®)
 
Journal club- Enteral Paracetamol or IV Indomethacin for closure of PDA
Journal club- Enteral Paracetamol or IV Indomethacin for closure of PDAJournal club- Enteral Paracetamol or IV Indomethacin for closure of PDA
Journal club- Enteral Paracetamol or IV Indomethacin for closure of PDA
 
Chronic liver disease in children 2021
Chronic liver disease in children 2021Chronic liver disease in children 2021
Chronic liver disease in children 2021
 
Acute-on-chronic liver failure (ACLF).pptx
Acute-on-chronic liver failure (ACLF).pptxAcute-on-chronic liver failure (ACLF).pptx
Acute-on-chronic liver failure (ACLF).pptx
 
Sepsis power point presentation
Sepsis power point presentationSepsis power point presentation
Sepsis power point presentation
 
Dengue CME.pptx
Dengue CME.pptxDengue CME.pptx
Dengue CME.pptx
 
Mortality Meet Presentation 2 by Dr. Saumya Agarwal
Mortality Meet Presentation 2 by Dr. Saumya Agarwal Mortality Meet Presentation 2 by Dr. Saumya Agarwal
Mortality Meet Presentation 2 by Dr. Saumya Agarwal
 
Surviving Sepsis Guidelines Updated
Surviving Sepsis Guidelines UpdatedSurviving Sepsis Guidelines Updated
Surviving Sepsis Guidelines Updated
 
Acquired hemophilia a
Acquired hemophilia aAcquired hemophilia a
Acquired hemophilia a
 

En vedette

Journal Club: Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
Journal Club: Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary SyndromesJournal Club: Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
Journal Club: Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary SyndromesJoy Awoniyi
 
Journal club presentation 10 07 2015
Journal club presentation 10 07 2015Journal club presentation 10 07 2015
Journal club presentation 10 07 2015Samuel Kariuki
 
Obesity & Asthma Journal
Obesity & Asthma JournalObesity & Asthma Journal
Obesity & Asthma Journalliza mariposque
 
Journal Club: Fidaxomicin versus Vancomycin for Clostridium Difficile Infection
Journal Club: Fidaxomicin versus Vancomycin for Clostridium Difficile InfectionJournal Club: Fidaxomicin versus Vancomycin for Clostridium Difficile Infection
Journal Club: Fidaxomicin versus Vancomycin for Clostridium Difficile InfectionJoy Awoniyi
 
Surfactant administration - Take care technique -Journal club
Surfactant administration - Take care technique -Journal clubSurfactant administration - Take care technique -Journal club
Surfactant administration - Take care technique -Journal clubgopan2596
 
Journal club presentation thyroid
Journal club presentation thyroidJournal club presentation thyroid
Journal club presentation thyroidimrana tanvir
 
How to present a journal club
How to present a journal clubHow to present a journal club
How to present a journal clubsanch1684
 
Journal club 1- Randomized trial of Hyperglycemic control in PICU
Journal club 1- Randomized trial of Hyperglycemic control in PICUJournal club 1- Randomized trial of Hyperglycemic control in PICU
Journal club 1- Randomized trial of Hyperglycemic control in PICUZaheen Zehra
 
Final ipf journal club presentation
Final ipf journal club presentationFinal ipf journal club presentation
Final ipf journal club presentationkatejohnpunag
 
Journal club presentation (chest tube) _.pptx dr shakil
Journal club presentation (chest tube) _.pptx dr shakilJournal club presentation (chest tube) _.pptx dr shakil
Journal club presentation (chest tube) _.pptx dr shakilShakil Ahmad
 
Launch of Journal Club
Launch of Journal ClubLaunch of Journal Club
Launch of Journal ClubOmer Khan
 
SSHC Journal Club presentation on the The Journal of Infectious Disease Volu...
SSHC Journal Club presentation on the The  Journal of Infectious Disease Volu...SSHC Journal Club presentation on the The  Journal of Infectious Disease Volu...
SSHC Journal Club presentation on the The Journal of Infectious Disease Volu...Sydney Sexual Health Centre
 
Azithromycin for prevention of exacerbations of copd
Azithromycin for prevention of exacerbations of copdAzithromycin for prevention of exacerbations of copd
Azithromycin for prevention of exacerbations of copdWarawut Ia
 
Hepatitis c virus associated with renal disease
Hepatitis c virus associated with renal diseaseHepatitis c virus associated with renal disease
Hepatitis c virus associated with renal diseasemohamed hassan abbass
 
Welcome Address for Paris Banff Allograft Pathology Meeting June 6-10, 2011
Welcome Address for Paris Banff Allograft Pathology Meeting June 6-10, 2011Welcome Address for Paris Banff Allograft Pathology Meeting June 6-10, 2011
Welcome Address for Paris Banff Allograft Pathology Meeting June 6-10, 2011Kim Solez ,
 
BARTTER’S - GITELMAN’S - LIDDLE’S
BARTTER’S - GITELMAN’S - LIDDLE’SBARTTER’S - GITELMAN’S - LIDDLE’S
BARTTER’S - GITELMAN’S - LIDDLE’Smohamed hassan abbass
 

En vedette (20)

Journal Club: Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
Journal Club: Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary SyndromesJournal Club: Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
Journal Club: Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
 
journal presentation
 journal presentation journal presentation
journal presentation
 
Rituximab CJASN Journal Club
Rituximab CJASN Journal ClubRituximab CJASN Journal Club
Rituximab CJASN Journal Club
 
Journal club presentation 10 07 2015
Journal club presentation 10 07 2015Journal club presentation 10 07 2015
Journal club presentation 10 07 2015
 
Journal Club Presentation
Journal Club PresentationJournal Club Presentation
Journal Club Presentation
 
Obesity & Asthma Journal
Obesity & Asthma JournalObesity & Asthma Journal
Obesity & Asthma Journal
 
Journal Club: Fidaxomicin versus Vancomycin for Clostridium Difficile Infection
Journal Club: Fidaxomicin versus Vancomycin for Clostridium Difficile InfectionJournal Club: Fidaxomicin versus Vancomycin for Clostridium Difficile Infection
Journal Club: Fidaxomicin versus Vancomycin for Clostridium Difficile Infection
 
Surfactant administration - Take care technique -Journal club
Surfactant administration - Take care technique -Journal clubSurfactant administration - Take care technique -Journal club
Surfactant administration - Take care technique -Journal club
 
Journal club presentation thyroid
Journal club presentation thyroidJournal club presentation thyroid
Journal club presentation thyroid
 
How to present a journal club
How to present a journal clubHow to present a journal club
How to present a journal club
 
Journal club 1- Randomized trial of Hyperglycemic control in PICU
Journal club 1- Randomized trial of Hyperglycemic control in PICUJournal club 1- Randomized trial of Hyperglycemic control in PICU
Journal club 1- Randomized trial of Hyperglycemic control in PICU
 
Final ipf journal club presentation
Final ipf journal club presentationFinal ipf journal club presentation
Final ipf journal club presentation
 
Journal club presentation (chest tube) _.pptx dr shakil
Journal club presentation (chest tube) _.pptx dr shakilJournal club presentation (chest tube) _.pptx dr shakil
Journal club presentation (chest tube) _.pptx dr shakil
 
Launch of Journal Club
Launch of Journal ClubLaunch of Journal Club
Launch of Journal Club
 
SSHC Journal Club presentation on the The Journal of Infectious Disease Volu...
SSHC Journal Club presentation on the The  Journal of Infectious Disease Volu...SSHC Journal Club presentation on the The  Journal of Infectious Disease Volu...
SSHC Journal Club presentation on the The Journal of Infectious Disease Volu...
 
Azithromycin for prevention of exacerbations of copd
Azithromycin for prevention of exacerbations of copdAzithromycin for prevention of exacerbations of copd
Azithromycin for prevention of exacerbations of copd
 
Journal Club
Journal ClubJournal Club
Journal Club
 
Hepatitis c virus associated with renal disease
Hepatitis c virus associated with renal diseaseHepatitis c virus associated with renal disease
Hepatitis c virus associated with renal disease
 
Welcome Address for Paris Banff Allograft Pathology Meeting June 6-10, 2011
Welcome Address for Paris Banff Allograft Pathology Meeting June 6-10, 2011Welcome Address for Paris Banff Allograft Pathology Meeting June 6-10, 2011
Welcome Address for Paris Banff Allograft Pathology Meeting June 6-10, 2011
 
BARTTER’S - GITELMAN’S - LIDDLE’S
BARTTER’S - GITELMAN’S - LIDDLE’SBARTTER’S - GITELMAN’S - LIDDLE’S
BARTTER’S - GITELMAN’S - LIDDLE’S
 

Similaire à Journal Club: Daily Corticosteroids Reduce Infection-associated Relapses in Frequently Relapsing Nephrotic Syndrome: A Randomized Controlled Trial

Resistant urticaria tutorial ppt.
Resistant urticaria tutorial ppt.Resistant urticaria tutorial ppt.
Resistant urticaria tutorial ppt.Dr Daulatram Dhaked
 
Ibalizumab - Journal Club Handout (Holden Young - Roseman University of Healt...
Ibalizumab - Journal Club Handout (Holden Young - Roseman University of Healt...Ibalizumab - Journal Club Handout (Holden Young - Roseman University of Healt...
Ibalizumab - Journal Club Handout (Holden Young - Roseman University of Healt...HoldenYoung3
 
MDR/XDR by Dr Tasleem Arif
MDR/XDR by Dr Tasleem ArifMDR/XDR by Dr Tasleem Arif
MDR/XDR by Dr Tasleem ArifTASLEEM ARIF
 
Mdr, xdr by dr tasleem arif
Mdr, xdr by dr tasleem arifMdr, xdr by dr tasleem arif
Mdr, xdr by dr tasleem arifTASLEEM ARIF
 
Relapse Risk after Discontinuation of Risperidone in Alzheimer’s disease- Jou...
Relapse Risk after Discontinuation of Risperidone in Alzheimer’s disease- Jou...Relapse Risk after Discontinuation of Risperidone in Alzheimer’s disease- Jou...
Relapse Risk after Discontinuation of Risperidone in Alzheimer’s disease- Jou...RobinBaghla
 
Intensive Insulin Therapy In The Medical ICU
Intensive Insulin Therapy In The Medical ICUIntensive Insulin Therapy In The Medical ICU
Intensive Insulin Therapy In The Medical ICUMuhammad Badawi
 
Nivolumab vs Docetaxel in Lung SCC
Nivolumab vs Docetaxel in Lung SCCNivolumab vs Docetaxel in Lung SCC
Nivolumab vs Docetaxel in Lung SCCAbdelrahman Labban
 
T.1 ECA tuberculosis isoniazida rifampicina
T.1 ECA tuberculosis isoniazida rifampicinaT.1 ECA tuberculosis isoniazida rifampicina
T.1 ECA tuberculosis isoniazida rifampicinaEduardo Sandoval
 
Steroid Sensitive Nephrotic Syndrome
Steroid Sensitive Nephrotic SyndromeSteroid Sensitive Nephrotic Syndrome
Steroid Sensitive Nephrotic SyndromeSunilMulgund1
 
Delamanid for multidrug resistant pulmonary tuberculosis
Delamanid for multidrug resistant pulmonary tuberculosisDelamanid for multidrug resistant pulmonary tuberculosis
Delamanid for multidrug resistant pulmonary tuberculosisHaroon Rashid
 
Lupus Nephritis Dilemma - Prof. Mohsen El Kosi
Lupus Nephritis Dilemma - Prof. Mohsen El KosiLupus Nephritis Dilemma - Prof. Mohsen El Kosi
Lupus Nephritis Dilemma - Prof. Mohsen El KosiMNDU net
 
3- vs 5-day antibiotic therapy in CAP
3- vs 5-day antibiotic therapy in CAP3- vs 5-day antibiotic therapy in CAP
3- vs 5-day antibiotic therapy in CAPKimberly Treier
 
Nephrotic syndrome
Nephrotic syndrome Nephrotic syndrome
Nephrotic syndrome maliha shah
 
Switching therapy in Multiple sclerosis
Switching therapy in Multiple sclerosisSwitching therapy in Multiple sclerosis
Switching therapy in Multiple sclerosisDivya Shilpa
 

Similaire à Journal Club: Daily Corticosteroids Reduce Infection-associated Relapses in Frequently Relapsing Nephrotic Syndrome: A Randomized Controlled Trial (20)

Journal club old
Journal club oldJournal club old
Journal club old
 
Rituximab Journal Club
Rituximab Journal ClubRituximab Journal Club
Rituximab Journal Club
 
Resistant urticaria tutorial ppt.
Resistant urticaria tutorial ppt.Resistant urticaria tutorial ppt.
Resistant urticaria tutorial ppt.
 
Rituximab Journal Club
Rituximab Journal ClubRituximab Journal Club
Rituximab Journal Club
 
2016 Sessions: 3 recent advances in oi management
2016 Sessions: 3 recent advances in oi management2016 Sessions: 3 recent advances in oi management
2016 Sessions: 3 recent advances in oi management
 
Ibalizumab - Journal Club Handout (Holden Young - Roseman University of Healt...
Ibalizumab - Journal Club Handout (Holden Young - Roseman University of Healt...Ibalizumab - Journal Club Handout (Holden Young - Roseman University of Healt...
Ibalizumab - Journal Club Handout (Holden Young - Roseman University of Healt...
 
MDR/XDR by Dr Tasleem Arif
MDR/XDR by Dr Tasleem ArifMDR/XDR by Dr Tasleem Arif
MDR/XDR by Dr Tasleem Arif
 
Mdr, xdr by dr tasleem arif
Mdr, xdr by dr tasleem arifMdr, xdr by dr tasleem arif
Mdr, xdr by dr tasleem arif
 
Relapse Risk after Discontinuation of Risperidone in Alzheimer’s disease- Jou...
Relapse Risk after Discontinuation of Risperidone in Alzheimer’s disease- Jou...Relapse Risk after Discontinuation of Risperidone in Alzheimer’s disease- Jou...
Relapse Risk after Discontinuation of Risperidone in Alzheimer’s disease- Jou...
 
Intensive Insulin Therapy In The Medical ICU
Intensive Insulin Therapy In The Medical ICUIntensive Insulin Therapy In The Medical ICU
Intensive Insulin Therapy In The Medical ICU
 
Nivolumab vs Docetaxel in Lung SCC
Nivolumab vs Docetaxel in Lung SCCNivolumab vs Docetaxel in Lung SCC
Nivolumab vs Docetaxel in Lung SCC
 
T.1 ECA tuberculosis isoniazida rifampicina
T.1 ECA tuberculosis isoniazida rifampicinaT.1 ECA tuberculosis isoniazida rifampicina
T.1 ECA tuberculosis isoniazida rifampicina
 
Steroid Sensitive Nephrotic Syndrome
Steroid Sensitive Nephrotic SyndromeSteroid Sensitive Nephrotic Syndrome
Steroid Sensitive Nephrotic Syndrome
 
Delamanid for multidrug resistant pulmonary tuberculosis
Delamanid for multidrug resistant pulmonary tuberculosisDelamanid for multidrug resistant pulmonary tuberculosis
Delamanid for multidrug resistant pulmonary tuberculosis
 
Journal club
Journal clubJournal club
Journal club
 
Lupus Nephritis Dilemma - Prof. Mohsen El Kosi
Lupus Nephritis Dilemma - Prof. Mohsen El KosiLupus Nephritis Dilemma - Prof. Mohsen El Kosi
Lupus Nephritis Dilemma - Prof. Mohsen El Kosi
 
3- vs 5-day antibiotic therapy in CAP
3- vs 5-day antibiotic therapy in CAP3- vs 5-day antibiotic therapy in CAP
3- vs 5-day antibiotic therapy in CAP
 
THERAPY OF PULMONARY TUBERCULOSIS WITH MULTIDRUG-RESISTANT MYCOBACTERIUM TUBE...
THERAPY OF PULMONARY TUBERCULOSIS WITH MULTIDRUG-RESISTANT MYCOBACTERIUM TUBE...THERAPY OF PULMONARY TUBERCULOSIS WITH MULTIDRUG-RESISTANT MYCOBACTERIUM TUBE...
THERAPY OF PULMONARY TUBERCULOSIS WITH MULTIDRUG-RESISTANT MYCOBACTERIUM TUBE...
 
Nephrotic syndrome
Nephrotic syndrome Nephrotic syndrome
Nephrotic syndrome
 
Switching therapy in Multiple sclerosis
Switching therapy in Multiple sclerosisSwitching therapy in Multiple sclerosis
Switching therapy in Multiple sclerosis
 

Plus de Hofstra Northwell School of Medicine

Plus de Hofstra Northwell School of Medicine (20)

Amacing
AmacingAmacing
Amacing
 
Amacing
AmacingAmacing
Amacing
 
TA-TMA
TA-TMATA-TMA
TA-TMA
 
HSCT-TMA
HSCT-TMAHSCT-TMA
HSCT-TMA
 
TA-TMA
TA-TMATA-TMA
TA-TMA
 
TA-TMA
TA-TMATA-TMA
TA-TMA
 
HSCT-TMA
HSCT-TMAHSCT-TMA
HSCT-TMA
 
Acute Kidney Injury in the Cardiac Surgery Patient
Acute Kidney Injury in the Cardiac Surgery PatientAcute Kidney Injury in the Cardiac Surgery Patient
Acute Kidney Injury in the Cardiac Surgery Patient
 
Aki cticu final
Aki cticu finalAki cticu final
Aki cticu final
 
Primary hyperoxaluria and the Kidney
Primary hyperoxaluria and the KidneyPrimary hyperoxaluria and the Kidney
Primary hyperoxaluria and the Kidney
 
Obesity paradox
Obesity paradoxObesity paradox
Obesity paradox
 
Journal Club:Stem cells and Kidney Transplantation
Journal Club:Stem cells and Kidney TransplantationJournal Club:Stem cells and Kidney Transplantation
Journal Club:Stem cells and Kidney Transplantation
 
Proteinuria, A medical student prespective
Proteinuria, A medical student prespectiveProteinuria, A medical student prespective
Proteinuria, A medical student prespective
 
Journal Club:SuPAR and FSGS
Journal Club:SuPAR and FSGSJournal Club:SuPAR and FSGS
Journal Club:SuPAR and FSGS
 
FGF-23 and Mortality in Dialysis patients- Journal Club
FGF-23 and Mortality in Dialysis patients- Journal ClubFGF-23 and Mortality in Dialysis patients- Journal Club
FGF-23 and Mortality in Dialysis patients- Journal Club
 
Journal Club: Residual renal function
Journal Club: Residual renal functionJournal Club: Residual renal function
Journal Club: Residual renal function
 
Cystic disease of the kidney
Cystic disease of the kidneyCystic disease of the kidney
Cystic disease of the kidney
 
Viruses and the kidney
Viruses and the kidneyViruses and the kidney
Viruses and the kidney
 
Hematuria post transplant
Hematuria post transplantHematuria post transplant
Hematuria post transplant
 
Paraproteins and the Kidney
Paraproteins and the KidneyParaproteins and the Kidney
Paraproteins and the Kidney
 

Dernier

Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxRoyAbrique
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 

Dernier (20)

Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 

Journal Club: Daily Corticosteroids Reduce Infection-associated Relapses in Frequently Relapsing Nephrotic Syndrome: A Randomized Controlled Trial